1Gorde S G. Comparison of procoagulant activity in tissue culture medium from normal and transformed fibroblasts. Cancer Res, 1978, 38:2467-2469.
2Motokura T, Bloom T, Kim HG ,et al. A novel eyelin encoded by a bcl 1-linked candidate oncogene[J]. Nature, 1991,350(6318): 512- 515.
3Hartwell LH, Kastan MB. Cell cycle control and cancer[J]. Science, 1994, 266(5192): 1821-1828.
4Caputi M, Groeger AM, Esposito V, et al. Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen[J]. Am J Repir Cell Mol Biol, 1999, 20(4): 746-750.
5Giermasz A, Makowski M, Kozlowska E, et al. Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice[J]. Int J Cancer, 2002, 97 (6): 746-750.
1Ohta Y, Shimizu Y, Minato H, et al. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease [J]. Ann Thorac Surg,2006, 81(2) :427.
2Sawaoka H, Tmji S, Tsujii M, et al. Cyclooxygenase inhibitors sup-press angiogenesis and reduce tumor growth in vivo[J], lab Invest, 1999,79(12) : 1469.
3Ogasawara T, Kasamatsu N, Umezawa H, et al. Retrospective a nalysis of pemetrexed plus cisplatin chemotherapy for elderly ad- vanced non-small-cell lung cancer[J]. Gan To Kagaku Ryoho, 2011,38(11) :1813.
